Does an orphan drug policy make a difference in access? A comparison of Canada and Australia.

2 January 2020 - Canada has been discussing whether to implement an orphan drug policy for more than 25 years. Recently, ...

Read more →

FDA takes second action under international collaboration, approves new treatment option for patients with chronic lymphocytic leukaemia

21 November 2019 - Today, as part of Project Orbis, a collaboration with the Australian Therapeutic Goods Administration and Health Canada, ...

Read more →